References
- Thompson J S, Pearlman N. Cancer of the colon and rectum in high-risk patients. Dis Colon Rectum 1982; 25: 461–3
- Järvinen H J, Ovaska J, Mecklin J -P. Improvements in the treatment and prognosis of colorectal cancer. Br J Surg 1988; 75: 25–7
- Lynch H T, Bardawil W A, Harris R E, Lynch P M, Guirgis H A, Lynch J F. Multiple primary cancers and prolonged survival: familial colonic and endometrial cancer. Dis Colon Rectum 1978; 21: 165–8
- Lynch H T, Albano W A, Recabaren J, Lynch P M, Lynch J F, Elston R. Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypotheses 1981; 7: 1202–9
- Albano W A, Recabaren J A, Lynch H T, et al. Natural history of hereditary cancer of the breast and colon. Cancer 1982; 50: 360–3
- Sankila R, Aaltonen L A, Jarvinen H J, Mecklin J -P. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996; 110: 682–7
- Gyde S N, Prior P, Thompson H, Waterhouse J AH, Allan R N. Survival of patients with colorectal cancer complicating ulcerative colitis. Gut 1984; 25: 228–31
- Connel W R, Talbot I C, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35: 1419–23
- Vasen H FA, Mecklin J -P, Meera Khan P, Lynch H T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424–5
- Davis N C, Evans E B, Cohen J R, Theile D E. Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system. Dis Colon Rectum 1984; 27: 707–13
- Aaltonen L A, Peltomaki P, Leach F S, et al. Clues to the pathoghenesis of familial colorectal cancer. Science 1993; 260: 812–6
- Cunningham C, Dunlop M G. Molecular genetic basis of colorectal cancer susceptibility. Br J Surg 1996; 83: 321–9
- Bussey H JR. Familial Polyposis Coli (dissertation). The Johns Hopkins University Press, Baltimore, MD 1975
- Biilow S, Billow C, Faurschou Nielsen T, Karlsen L, Moesgaard F. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Scand J Gastroenterol 1995; 30: 989–93
- Heimann M T, Sangbaek C, Martinelli G, et al. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators. Am J Surg 1992; 164: 13–7
- Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut 1990; 31: 1089–92
- Lashner B A, Kane S V, Hanauer S B. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 1990; 85: 1083–7
- Mecklin J -P, Sipponen P, Jarvinen H J. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum 1986; 29: 849–53
- Jass J R, Stewart S M. Evolution of hereditary non-polyposis colorectal cancer. Gut 1992; 33: 783–6
- Ahlquist D A. Aggressive polyps in hereditary non-polyposis colorectal cancer: targets for screening. Gastroenterology 1995; 108: 1590–2
- Smyrk T C, Lynch H T, Watson P A, Appelman H D. Histologic features of hereditary non-polyposis colorectal carcinoma. Hereditary Colorectal Cancer, J Utsunomiya, H T Lynch. Springer-Verlag, Tokyo 1989; 357–62
- Kim H, Jen J, Vogelstein B, Hamilton S R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequencies. Am J Pathol 1994; 145: 148
- Shibata M, Peinado M A, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequencies is an early somatic event in colorectal tumourigenesis that persists after transformation. Nat Genet 1994; 6: 273–81
- Jass J R, Smyrk T C, Stewart S M, Lane M R, Lanspa S J, Lynch H T. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994; 14: 1631–4
- Jarvinen H J, Mecklin J -P, Sistonen P. Screening reduces colorectal cancer rate in hereditary non-polyposis colorectal cancer (HNPCC) families. Gastroenterology 1995; 108: 1405–11